1.42

2.07% 0.03

Celularity Inc (CELU)

Overview News Price History Option Chain Financials Discussions Forecast

Celularity Inc stock is traded at $1.42, with a volume of 9,846. It is up +2.07% in the last 24 hours and down -15.43% over the past month. Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Previous Close:

$1.45

Open:

$1.45

24h Volume:

9,846

Relative Volume:

0.08

Market Cap:

$41.44M

Revenue:

$48.20M

Net Income/Loss:

$-35.05M

P/E Ratio:

-0.906

EPS:

-1.5673

Net Cash Flow:

$-13.02M

1W Performance:

+5.71%

1M Performance:

-15.43%

6M Performance:

-15.91%

1Y Performance:

-36.48%

1-Day Range:

$1.4009

$1.48

1-Week Range:

$1.2488

$1.61

52-Week Range:

$1.06

$4.35

Celularity Inc Stock (CELU) Company Profile

Name

Celularity Inc

Sector

Healthcare (1135)

Industry

Biotechnology (633)

Phone

(908) 768-2170

Address

170 PARK AVE, FLORHAM PARK

Employee

123

Twitter

Next Earnings Date

2024-11-04

Latest SEC Filings

CELU's Discussions on Twitter

Compare CELU with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CELU Celularity Inc	1.4628	41.08M	48.20M	-35.05M	-13.02M	-1.5673
VRTX Vertex Pharmaceuticals Inc	457.89	115.75B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	778.45	80.71B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	410.92	52.88B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	855.42	52.64B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	178.13	37.29B	447.02M	-1.18B	-906.14M	-6.1812

Celularity Inc Stock (CELU) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Dec-22-22	Downgrade	Oppenheimer	Outperform → Perform
Jun-22-22	Initiated	H.C. Wainwright	Buy
Apr-06-22	Downgrade	Truist	Buy → Hold
Jan-28-22	Initiated	Oppenheimer	Outperform
Nov-24-21	Initiated	Morgan Stanley	Equal-Weight

View All

Celularity Inc Stock (CELU) Latest News

Dec 21, 2025

Is Celularity Inc. Equity Warrant stock a smart buy before Fed meetingJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - bolumsonucanavari.com

Dec 21, 2025

Why Celularity Inc. Equity Warrant stock could rally in 20252025 Price Action Summary & Verified Swing Trading Watchlist - DonanımHaber

Dec 21, 2025

Dec 20, 2025

Celularity Shareholders Reject Expansion of Equity Incentive Plan - The Globe and Mail

Dec 20, 2025

Can Celularity Inc. stock deliver surprise earnings beatJuly 2025 Earnings & AI Enhanced Trading Alerts - Улправда

Dec 20, 2025

Will Celularity Inc. stock outperform tech sector in 20252025 Volatility Report & Free High Accuracy Swing Entry Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Why Celularity Inc. Equity Warrant stock could benefit from AI revolutionJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - ulpravda.ru

Dec 19, 2025

Celularity raises $12m to sharpen longevity strategy - Longevity.Technology

Dec 19, 2025

What Wall Street predicts for Celularity Inc. Equity Warrant stock priceAnalyst Downgrade & Real-Time Sentiment Analysis - DonanımHaber

Dec 19, 2025

Is Celularity Inc. Equity Warrant stock dividend yield sustainable2025 Market Outlook & AI Based Buy and Sell Signals - DonanımHaber

Dec 19, 2025

Why Celularity Inc. stock is favored by top institutionsStop Loss & Weekly Watchlist for Hot Stocks - DonanımHaber

Dec 19, 2025

Will Celularity Inc. Equity Warrant stock outperform Dow Jones indexPortfolio Risk Report & Risk Controlled Swing Alerts - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Performance Recap: Will Celularity Inc. stock outperform tech sector in 2025Weekly Trade Summary & Growth Focused Stock Reports - moha.gov.vn

Dec 18, 2025

Why Celularity Inc. stock is favored by pension funds2025 Risk Factors & Precise Buy Zone Identification - Улправда

Dec 18, 2025

Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision - Investing News Network

Dec 18, 2025

Celularity secures up to $12 million in financing for longevity focus - Investing.com

Dec 18, 2025

Celularity Inc. Secures Up to $12 Million in Financing to Advance Strategic Priorities in Longevity and Human Performance - Quiver Quantitative

Dec 18, 2025

DoubleLine co-founder backs up to $12M funding plan for longevity - Stock Titan

Dec 18, 2025

Celularity Inc.'s (NASDAQ:CELU) 25% Dip In Price Shows Sentiment Is Matching Revenues - 富途牛牛

Dec 18, 2025

Dec 17, 2025

Celularity Inc. announced that it expects to receive $12 million in funding - marketscreener.com

Dec 17, 2025

Dec 15, 2025

There Is A Reason Celularity Inc.'s (NASDAQ:CELU) Price Is Undemanding - simplywall.st

Dec 15, 2025

Dec 14, 2025

Celularity Inc. (GXGXW) Fundamental Analysis - Meyka

Dec 14, 2025

Dec 13, 2025